Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a (31)P/(1)H MRSI and quantitative magnetic resonance imaging study

Bevacizumab shows unprecedented rates of response in recurrent glioblastomas (GBM), but the detailed mechanisms are still unclear. We employed in vivo magnetic resonance spectroscopic imaging (MRSI) and quantitative magnetic resonance imaging to investigate whether bevacizumab alters oxygen and ener...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hattingen, Elke, Jurcoane, Alina, Bähr, Oliver, Rieger, Johannes, Magerkurth, Jörg, Anti, Sandra, Steinbach, Joachim P., Pilatus, Ulrich
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2011
Soggetti:
Clinical Investigations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3223092/
https://ncbi.nlm.nih.gov/pubmed/21890539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nor132
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi